Gamma-hydrobutyric acid (GHB) and its chemical modifications: a review of the GHBergic system - PubMed

Affiliations

• PMID: 15047976

Free article

Review

Gamma-hydrobutyric acid (GHB) and its chemical modifications: a review of the GHBergic system

Anna Waszkielewicz et al. Pol J Pharmacol. 2004 Jan-Feb.

Free article

Abstract

Gamma-hydroxybutyric acid (GHB) is a naturally occurring substance with function of an inhibitory neurotransmitter in the central nervous system in mammals. GHB can be used as a medicine in narcolepsy (Xyrem) and for general anesthesia (sodium oxybate). It is also a popular drug of abuse, causing coma, addiction and severe withdrawal syndrome, and, therefore, demanding thorough studies on the GHBergic system and expanded research on toxicology of this compound. The aim of this review is to present the proved and some suggested mechanisms of its action from pharmacological point of view, which may help to properly treat intoxication or other pathological states caused by GHB ingestion. Some new GHB derivatives studied for analogous action and their present use are also described.

Similar articles

• [Update on gamma-hydroxybutyric acid].

  García FB, Pedraza C, Navarro JF. García FB, et al. Rev Neurol. 2006 Jul 1-15;43(1):39-48. Rev Neurol. 2006. PMID: 16807871 Review. Spanish.

• [Gamma-hydroxy butyric acid: neurotransmitter, sedative and party drug].

  Meyer S, Kleinschmidt S, Gottschling S, Gortner L, Strittmatter M. Meyer S, et al. Wien Med Wochenschr. 2005 Jul;155(13-14):315-22. doi: 10.1007/s10354-005-0174-4. Wien Med Wochenschr. 2005. PMID: 16092038 Review. German.

• Reliable, sensitive, rapid and quantitative enzyme-based assay for gamma-hydroxybutyric acid (GHB).

  Bravo DT, Harris DO, Parsons SM. Bravo DT, et al. J Forensic Sci. 2004 Mar;49(2):379-87. J Forensic Sci. 2004. PMID: 15027565

• [Gamma-hydroxybutyric acid (GHB) dependence and the GHB withdrawal syndrome: diagnosis and treatment].

  van Noorden MS, Kamal R, de Jong CA, Vergouwen AC, Zitman FG. van Noorden MS, et al. Ned Tijdschr Geneeskd. 2010;154:A1286. Ned Tijdschr Geneeskd. 2010. PMID: 21040601 Review. Dutch.

• Novel high-affinity and selective biaromatic 4-substituted gamma-hydroxybutyric acid (GHB) analogues as GHB ligands: design, synthesis, and binding studies.

  Høg S, Wellendorph P, Nielsen B, Frydenvang K, Dahl IF, Bräuner-Osborne H, Brehm L, Frølund B, Clausen RP. Høg S, et al. J Med Chem. 2008 Dec 25;51(24):8088-95. doi: 10.1021/jm801112u. J Med Chem. 2008. PMID: 19053823

Cited by

• ECOMICS: a web-based toolkit for investigating the biomolecular web in ecosystems using a trans-omics approach.

  Ogata Y, Chikayama E, Morioka Y, Everroad RC, Shino A, Matsushima A, Haruna H, Moriya S, Toyoda T, Kikuchi J. Ogata Y, et al. PLoS One. 2012;7(2):e30263. doi: 10.1371/journal.pone.0030263. Epub 2012 Feb 1. PLoS One. 2012. PMID: 22319563 Free PMC article.

• Increasing Evidence for the Use of Sodium Oxybate in Multi-Drug-Resistant Lance-Adams Syndrome.

  Riboldi GM, Frucht SJ. Riboldi GM, et al. Tremor Other Hyperkinet Mov (N Y). 2019 Jun 17;9. doi: 10.7916/d8-rnsh-c024. eCollection 2019. Tremor Other Hyperkinet Mov (N Y). 2019. PMID: 31413889 Free PMC article.

• Sodium Oxybate in Alcohol-Responsive Essential Tremor of Voice: An Open-Label Phase II Study.

  O'Flynn LC, Frucht SJ, Simonyan K. O'Flynn LC, et al. Mov Disord. 2023 Oct;38(10):1936-1944. doi: 10.1002/mds.29529. Epub 2023 Jul 14. Mov Disord. 2023. PMID: 37448353 Free PMC article. Clinical Trial.

• A novel therapeutic agent, sodium oxybate, improves dystonic symptoms via reduced network-wide activity.

  Simonyan K, Frucht SJ, Blitzer A, Sichani AH, Rumbach AF. Simonyan K, et al. Sci Rep. 2018 Oct 31;8(1):16111. doi: 10.1038/s41598-018-34553-x. Sci Rep. 2018. PMID: 30382161 Free PMC article. Clinical Trial.

• Metabolomic study of polyamines in rat urine following intraperitoneal injection of γ-hydroxybutyric acid.

  Lee HS, Seo C, Kim YA, Park M, Choi B, Ji M, Lee S, Paik MJ. Lee HS, et al. Metabolomics. 2019 Apr 2;15(4):58. doi: 10.1007/s11306-019-1517-2. Metabolomics. 2019. PMID: 30941522

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Institute of Pharmacology Polish Academy of Sciences

• Other Literature Sources

  • The Lens - Patent Citations Database